Read more
-
Korean obesity drug Eppe takes on Mounjaro, Wegovy with slimmer price tag
Hanmi Pharmaceutical plans to launch Korea’s first homegrown GLP-1 obesity treatment at wholesale prices well below Eli Lilly and Novo Nordisk's products.
-
Banking blind spot? 6 in 10 financial incidents go unnoticed for over a year.
FSS data showed that financial misconduct cases at Korea’s five major banks went undetected for long periods, with almost 10 percent taking five years to be identified.
-
BOK's Shin highlights need to curb inflation amid chip boom, Middle East conflict
Bank of Korea Gov. Shin Hyun-song cited the need to “get inflation down,” and added that getting monetary policy right was “absolutely key” ahead of next week’s rate meeting.
-
Korea ranks 22nd in broadband, 6th in mobile in global internet speed test
The fixed broadband result of 251.33 megabits per second was contested by the Ministry of Science and ICT, which claimed higher speeds.